1.Minimally Invasive Anterior Approach in Open Reduction of Displaced Supracondylar Fractures of Humerus in Children.
Chang Ryung HUR ; Seung Woo SUH ; Chang Ug OH ; In Jung CHAE ; Jun Gyu MOON ; Chan Eung PARK ; Jae Young HONG
Journal of the Korean Fracture Society 2005;18(2):185-190
PURPOSE: To evaluate the outcomes of minimal anterior approach and thumb assisted technique, in children with Gartland type III supracondylar humerus fracture, who were operated by this technique. MATERIALS AND METHODS: Forty two children with Gartland type III supracondylar fractures of the humerus with severe swelling were taken up for minimal open reduction and K-wire fixation. The technique used was a minimal incision in the cubital fossa and thumb assisted reduction of the fracture. Stabilization of fractures was done with 1.6 mm Kirschner wires. RESULTS: The outcomes were excellent in 40 cases good in 2 cases. No complications including malunion or scar contracture were seen. CONCLUSION: This technique is safe, effective and can be used for irreducible, displaced supracondylar fractures of the humerus in children
Bone Wires
;
Child*
;
Cicatrix
;
Contracture
;
Humans
;
Humerus*
;
Thumb
2.The Effect of Cervical Sympathetic Nerve Block on Blood-brain Barrier Disruption with Mannitol Infusion in Rats.
Bong Ki MOON ; Soo Han YOON ; Young Joo LEE ; Chul Ryung HUR ; Chang Ho KIM ; Sung Jung LEE ; Young Seok LEE
The Korean Journal of Critical Care Medicine 1997;12(1):69-74
BACKGOUND: The barrier can be altered by a number of insults to the brain (e.g., hypertension, freezing, trauma, drug). But the effect of the blood brain barrier distruction immediately after the neural change is unknown. In the present study, we focused on the BBBD after cervical sympathetic chain block. METHODS: 13 male Sprague-Dawley rats were divided into 2 groups. Group 1 (N=7) was blocked with 0.5% bupivacaine on the right cervical sympathetic chain and group 2 (N=6) was blocked with 0.5% bupivacaine on the bilateral cervical sympathetic chain. All rats received 37degrees C, 25% mannitol (1.75 g/kg) via right carotid artery and then, the effect of cervical sympathetic chain block on blood-brain barrier disruption of four cerebral compartment using 99mTc-human serum albumin and Evans blue was evaluated. RESULTS: Both groups showed blood-brain barrier disruption and there was no significant difference between group 1 and group 2 in the anterior and posterior hemisphere of the right side brain. But group 2 showed significant blood-brain barrier disruption than group 1 in anterior and posterior hemisphere of the left brain (p<0.01). CONCLUSIONS: This results suggest that cervical sympathetic chain block can increase the degree of mannitol-induced blood-brain barrier disruption via neural arch or blood flow change.
Anesthetics
;
Animals
;
Autonomic Nerve Block*
;
Blood-Brain Barrier*
;
Brain
;
Bupivacaine
;
Carotid Arteries
;
Evans Blue
;
Freezing
;
Humans
;
Hypertension
;
Male
;
Mannitol*
;
Rats*
;
Rats, Sprague-Dawley
;
Technetium Tc 99m Aggregated Albumin
3.A Case of Chylous Ascites Associated with Non-Hodgkin's Lymphoma and Liver Cirrhosis.
Hyung Suk JI ; Min Hee RYU ; Joo Ryung HUR ; Jung Min CHOI ; Heung Moon CHANG ; Tae Won KIM ; Jung Shin LEE ; Woo Kun KIM ; Yoon Koo KANG
Korean Journal of Hematology 2002;37(3):236-240
Chylous effusion is an unusual complication of malignant neoplasm, usually lymphoma. In cases with cancer, the tumor was usually extensive, and the prognosis was invariably poor with a one year mortality rate of 80%. It was also reported that chylous effusion could also result from liver cirrhosis. The incidence of this complication was reported to be 0.5% in patients with liver cirrhosis and ascites. Here we report a case of 62 year old male with chronic alcoholism history who presented with abdom-inal distension and right cervical mass. He was subsequently diagnosed as non-Hodgkin's lymphoma and chylous ascites with liver cirrhosis and treated with chemotherapy. In spite of treatment, lymphoma progressed and the patient expired.
Alcoholism
;
Ascites
;
Chylous Ascites*
;
Drug Therapy
;
Humans
;
Incidence
;
Liver Cirrhosis*
;
Liver*
;
Lymphoma
;
Lymphoma, Non-Hodgkin*
;
Male
;
Middle Aged
;
Mortality
;
Prognosis